S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Ligand Partner Retrophin Receives Orphan Drug Designation for Sparsentan (2015/1/9)|
|SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Retrophin, Inc. To Contact Brower Piven Before The December 19, 2014 Lead Plaintiff Deadline In Class Action Lawsuit (2014/12/1)|
|INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Retrophin, Inc. (2014/12/10)|
|Attention Retrophin, Inc. (RTRX) Shareholders: Retrophin Mislead Investors According to a Newly Filed Class Action (2014/12/22)|
|SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Retrophin, Inc. of Class Action Lawsuit and Upcoming Deadline -- RTRX (2014/12/12)|
|Retrophin Announces Voting Results of Special Meeting of Stockholders (2015/2/3)|
|Ryan & Maniskas, LLP Announces Investigation of Retrophin, Inc. (2015/1/9)|
|Updated: Harwood Feffer LLP Announces Investigation of Retrophin, Inc. (2015/1/8)|
|UPCOMING DEADLINE: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against Retrophin, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 19, 2014 -- RTRX (2014/12/1)|
|Retrophin Announces Acquisition of Exclusive Right to Purchase Cholic Acid from Asklepion Pharmaceuticals (2015/1/12)|
Click above to view more mutual fund data and stats for rtrx - Retrophin Inc.